Vulpes Investment Management Pte Ltd
Signal active
Investment Firm
Overview
N/A
Highlights
Founded
2011
Industry
Employees
11-50
Investment
16
Lead Investment
5
Exits
4
Stages
Seed, Early Stage Venture
Investor Type
Hedge Fund, Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Vulpes Investment Management Pte Ltd, established in 2011 and headquartered in Asia., specializes in Seed, Early Stage Venture investments across Biotechnology, Health Care, Therapeutics, Education, Association, E-Learning, Knowledge Management, Universities, Financial Services, Venture Capital. The organization boasts a portfolio of 15 investments, with an average round size of $8.6M and 4 successful exits. Their recent investments include Chronos Therapeutics, University of Oxford, Odey Asset Management, PactSafe, Rosemary Health. The highest investment round they participated in was $4.6B. Among their most notable exits are Chronos Therapeutics and University of Oxford. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Vulpes Investment Management Pte Ltd has made 16 investments. Their most recent investment was on May 20, 2024, when Oxford Endovascular raised $10.2M.
investments
16
Diversity investments
0
Lead investments
5
Number of exits
4
Investments
16
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Oct 21, 2021 | Leucid Bio | Biotechnology | 15.9M |
| Oct 29, 2021 | Citics | Software | 1.3M |
| Jan 18, 2022 | MyRobin.id | Big Data | null |
| May 20, 2024 | Oxford Endovascular | Biotechnology | 10.2M |
Exits
4
Funding Timeline
Funding rounds
16
Investors
0
Funds
0
Funding Rounds
16
Vulpes Investment Management Pte Ltd has raised 16 rounds. Their latest funding was raised on May 20, 2024 from a Series A - Oxford Endovascular round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Oct 21, 2021 | Series A - Leucid Bio | - | 15.9M | - |
| Oct 29, 2021 | Convertible Note - Citics | - | 1.3M | - |
| Jan 18, 2022 | Seed Round - MyRobin.id | - | 0 | - |
| May 20, 2024 | Series A - Oxford Endovascular | - | 10.2M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.